Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Initial and Maintenance Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Thai Adults
NCT03228862Phase 4Unknown
- Sponsor
- Chulalongkorn University
- Start
- May 2017
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (3 arms), sponsored by Chulalongkorn University. Primary endpoint: Serum 25-hydroxyvitamin D concentration at 12 weeks. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03228862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228862.